Trials / Completed
CompletedNCT04579302
Serratus Anterior Block and Erector Spinae Block in Postoperative Analgesia
Evaluation of the Effect of Serratus Anterior Block and Erector Spinae Block on Postoperative Analgesia in Thoracic Surgeries
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- National Cancer Institute, Egypt · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
90 patients scheduled for thoracic cancer surgeries, allocated in 3 groups for serratus anterior block and erector spinae block and control group. during anaesthesia:total intraoperative fentanyl required will be recorded. After surgery, all patients will be connected to PCA device containing morphine solution, the amount of morphine consumed during the first 24 hours will be recorded.
Detailed description
90 patients scheduled for thoracic cancer surgeries, allocated in 3 groups for serratus anterior block (SAB) and erector spinae block (ESB) and control group. During anaesthesia: total intraoperative fentanyl required will be recorded. After surgery, all patients will be connected to PCA device containing morphine solution, the amount of morphine consumed during the first 24 hours will be recorded. Other secondary outcomes are: numerical rating scales and postoperative pulmonary functions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Serratus anterior block (SAB) | Patients will receive a sonar guided serratus anterior plane block with 20 ml of bupivacaine 0.5% |
| PROCEDURE | Erector spinae block | Patients will receive a sonar-guided erector spinae plane block with 20 ml of bupivacaine 0.5% |
| DRUG | Saline (as a placebo) | Patients will receive a sham block with 20 ml saline (as a placebo) |
| DRUG | Bupivacaine | bupivacaine |
Timeline
- Start date
- 2020-11-01
- Primary completion
- 2021-02-28
- Completion
- 2021-02-28
- First posted
- 2020-10-08
- Last updated
- 2021-03-09
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04579302. Inclusion in this directory is not an endorsement.